Switzerland's Galderma nine-month sales rise on higher volumes, lifts outlook

Galderma AG

Today 06:08

Overview
Switzerland dermatology firm's nine-month net sales rose 25.1% yr/yr at constant currency
Company raised 2026 full-year net sales growth guidance to 22.5-23.5% at constant currency
Previously announced ZO Skin Health acquisition expected to close late 2026 or early 2027

Outlook
Galderma raises 2026 net sales growth guidance to 22.5-23.5% at constant currency
Company confirms 2026 Core EBITDA margin guidance of approximately 26% at constant currency
Guidance excludes ZO Skin Health acquisition, expected to close in Q4 2026 or early 2027

Result Drivers
THERAPEUTIC DERMATOLOGY - Strong growth in Therapeutic Dermatology, particularly from Nemluvio and the mature portfolio, drove results
VOLUME GROWTH - Net sales increase was predominantly driven by higher volumes, complemented by favorable product mix
DERMATOLOGICAL SKINCARE AND NEUROMODULATORS - Continued strong demand in Dermatological Skincare and Neuromodulators contributed to overall growth

Company press release: ID:nBw2HtTbHa

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
9M Sales
 
$4.77 bln
 

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 15 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the personal products peer group is "buy"
Wall Street's median 12-month price target for Galderma Group AG is CHF200.00, about 14.8% above its October 21 closing price of CHF174.25

Reuters Recommended Reads
Oct 21 - Roche says experimental MS pill cuts relapses by 55% in late-stage trials
Oct 19 - Novartis ends mid-stage Fabhalta trial targeting serious kidney condition
Oct 21 - Beauty giants target 'Ozempic face' as boom in obesity drugs opens new market

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)